Corixa Company
Corixa is a developer of immunotherapeutics focused on treating and preventing autoimmune diseases, cancer and infectious diseases
Investors
Connections from
Industry:
Whole-Cell Antigens
Funding Status:
M&A
Investors Number:
6
Headquarters:
Seattle, Washington, United States
Employee Number:
1-10
Total Funding:
15000000
Founded Date:
1994-01-01
Last Funding Type:
Venture - Series Unknown
Last Funding Date:
1996-01-01